Manufacturing dexamethasone intravitreal implants: Process control and critical quality attributes-Reference-Cited by-同舟云学术

Manufacturing dexamethasone intravitreal implants: Process control and critical quality attributes

Published:2023-11 Issue: Volume:647 Page:123515
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Costello Mark A.^ORCID,Liu Joseph,Wang Yan,Qin Bin,Xu Xiaoming^ORCID,Li Qi,Smith William C.,Lynd Nathaniel A.,Zhang Feng^ORCID

Funder

US Food and Drug Administration

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. A study of drug release from homogeneous PLGA microstructures;Acharya;J. Control. Release.,2010

2. Allergan, 2022. Highlights of Prescribing Information, OZURDEX (dexamethasone intravitreal implant). https://www.rxabbvie.com/pdf/ozurdex_pi.pdf (accessed 06 February 2023).

3. ASTM D7264/D7264M−21. Standard Test Method for Flexural Properties of Polymer Matrix Composite Materials. West Conshohocken, PA: ASTM International; 2021.

4. Comparison of the tissue penetration and glide force of 22-gauge thin-wall needles for intravitreal implant administration;Bakri;Ophthalmic. Surg. Lasers. Imaging. Retina.,2014

5. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes;Bhagat;J. Ocul. Pharmacol. Ther.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of poly (lactic-co-glycolic acid) (PLGA) based implants using hot melt extrusion (HME) for sustained release of drugs: The impacts of PLGA’s material characteristics;International Journal of Pharmaceutics;2024-09

2. Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants;Molecular Pharmaceutics;2023-11-13